Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 9, 2011

 

Drug Name

 Review Type Class Manufacturer
Pradaxa New Drug Initial Review Direct Thrombin Inhibitor Boehringer Ingelheim
Veregen New Drug Initial Review Topical Genital Wart � HPV Treatment Agent PharmaDerm
Latuda New Drug Initial Review Antipsychotic Sunovion
Kapvay New Drug Initial Review Alpha-2 Adrenergic Agent Shionogi Pharma
Fanapt New Drug Appeal Atypical Antipsychotic Novartis
Pegasys PDL Appeal Hepatitis B and C Agent Genentech